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ABSTRACT 
Introduction. Peritubular capillary complement 4d 
staining is one of the criteria for the diagnosis of 
antibody-mediated rejection, and research into this 
is essential to kidney allograft evaluation. The immu-
nofluorescence technique applied to frozen sections 
is the present gold-standard method for complement 
4d staining and is used routinely in our laboratory. 
The immunohistochemistry technique applied to 
paraffin-embedded tissue may be used when no 
frozen tissue is available.
Material and Methods. The aim of this study is to 
evaluate the sensitivity and specificity of immunohis-
tochemistry compared with immunofluorescence. We 
describe the advantages and disadvantages of the 
immunohistochemistry vs. the immunofluorescence 
technique. For this purpose complement 4d staining 
was performed retrospectively by the two methods 
in indication biopsies (n=143) and graded using the 
Banff 07 classification.
Results. There was total classification agreement 
between methods in 87.4% (125/143) of cases. How-
ever, immunohistochemistry staining caused more dif-
ficulties in interpretation, due to nonspecific staining 
in tubular cells and surrounding interstitium. All cases 
negative by immunofluorescence were also negative 
by immunohistochemistry. The biopsies were classified 
as positive in 44.7% (64/143) of cases performed by 
immunofluorescence vs. 36.4% (52/143) performed by 
immunohistochemistry. Fewer biopsies were classified 
as positive diffuse in the immunohistochemistry group 
(25.1% vs. 31.4%) and more as positive focal (13.2% 
vs. 11.1%). More cases were classified as negative by 
immunohistochemistry (63.6% vs. 55.2%). Study by 
ROC curve showed immunohistochemistry has a speci-
ficity of 100% and a sensitivity of 81.2% in relation to 
immunofluorescence (AUC: 0.906; 95% confidence 
interval: 0.846-0.949; p=0.0001).
Conclusions. The immunohistochemistry method 
presents an excellent specificity but lower sensitivity 
to C4d detection in allograft dysfunction. The evalu-
ation is more difficult, requiring a more experienced 
observer than the immunofluorescence method. 
Based on these results, we conclude that the immu-
nohistochemistry technique can safely be used when 
immunofluorescence is not available.
Key-Words:
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INTRODUCTION 
Complement 4d (C4d) is a fragment of the clas-
sical complement pathway component C4, which is 
activated by antigen-antibody complexes. C4 is acti-
vated and proteolytically cleaved into C4a and C4b 
which have a reactive thiolester group that binds to 
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nearby molecules covalently. C4b is later inactivated 
by cleavage into C4c and C4d. This fragment contains 
the covalent bond to the tissue and remains at the 
site of complement activation for longer periods, in 
contrast with other complement fragments1.
In renal transplantation the presence of specific 
antidonor antibodies reacting with the graft endothe-
lium activates the classical complement pathway 
which leads to the deposition of C4d in peritubular 
capillaries (PTC)2. The knowledge that C4d in peri-
tubular capillary persist for prolonged periods allowed 
the recognition of antibody-mediated process in acute 
and chronic renal transplant dysfunction.
Antibody-mediated renal transplant rejection can 
be divided into four different types: hyperacute rejec-
tion, acute humoral rejection (AHR), chronic humoral 
rejection (CHR) and, according to some authors, 
accommodation. Hyperacute rejection presents with 
immediate graft failure, minutes or hours after rep-
erfusion, while in accommodation there is antibody 
and complement deposition in the PTC, but the graft 
function and histology are not affected. Also AHR 
and CHR present PTC C4d deposits but have different 
clinical and histological characteristics. AHR is char-
acterised by acute injury lesions, such as the presence 
of neutrophils and macrophages in glomeruli and 
PTC, acute tubular injury and sometimes fibrinoid 
arterial necrosis. CHR is characterised by chronic injury 
lesions such as glomerular basement membrane dupli-
cation, mononuclear cells in glomeruli and PTC, intimal 
fibrosis, tubular atrophy and interstitial fibrosis, peri-
tubular basement membrane reduplication3.
In both AHR and CHR the presence of C4d deposits 
in PTC is crucial to distinguish them from other 
nonantibody-mediated rejections2,4.
Renal grafts with C4d deposits in PTC have lower 
survival rates than grafts without C4d, especially 
when C4d deposition occurs early after transplant.
C4d staining score in renal grafts has been divided 
into four categories according to the percentage of 
staining area: C4d negative (0%); C4d positive minimal 
(1<10%); C4d positive focal (10<50%); C4d positive dif-
fuse (>50%). This score was established by the patterns 
observed by immunofluorescence (IF). The C4d deposi-
tion evaluation on PTC can be made in both cortex 
and medulla without scarring or infarction5.
Minimal staining is considered as negative. The 
diffuse staining is defined as positive, but the clinical 
and histological relevance of focal staining is not 
yet established. Some studies suggested that focal 
staining may be associated with glomerulitis and 
capillaritis6 while others stated that focal C4d cases 
may have an intermediate prognosis between diffuse 
and negative cases7. Some studies had been made 
comparing staining of C4d by IF and immunohis-
tochemistry (IHC).
Adasdy et al.8 compared a three-step IF method 
on frozen sections, a two-step IF method on frozen 
sections and an IHC method in formalin-fixed, paraffin-
embedded (FFPE) tissue using different antibodies 
in twenty biopsies. They concluded that the three-step 
IF method appeared to be the most sensitive and 
IHC the less sensitive.
Troxell et al.9 compared indirect IF with the mono-
clonal antibody anti-C4d from Quidel™ (ref. A213) 
and IHC with the polyclonal antibody anti-C4d from 
Biomedica Gruppe Austria™ in 107 biopsies (26 posi-
tive) and, establishing the IF method as the gold 
standard, found that the IHC specificity was 98% 
and sensitivity 87.5%. They also referred to the dif-
ficult interpretation of IHC, which is due to unspecific 
background staining. This study also confirmed the 
observation of Regele et al.10 that normal glomeruli 
show mesangial C4d staining with an IF method in 
frozen tissue but not with an IHC method in FFPE 
tissue.
Seemayer et al.11 compared the same antibodies 
and methods as the previous study in 64 biopsies. 
They concluded that, on average, the degree of C4d 
staining with an IHC method was lower by about a 
degree, which means that many diffusely staining 
cases in IF method turned focally positive in the IHC 
method. They also observed that in normal renal 
tissue C4d was detected in the mesangium of the 
glomeruli in frozen tissues but not in FFPE tissues. 
In the presence of glomerular damage a strong C4d 
staining of the glomerular basement membrane was 
detected by both methods. The endothelia of arteries 
and arterioles were sometimes positive.
All three studies recommended the use of the IF 
method in frozen tissue. However, a biopsy does 
not always have enough material for conventional 
processing (FFPE) and to be frozen for IF.
C4d detection in renal allograft biopsies: immunohistochemistry vs. immunofluorescence
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MATERIAL AND METHODS 
The aim of our study was to evaluate the sensibil-
ity and specificity of IHC compared to the gold-
standard method and to establish the safety of IHC 
use when IF is not available.
The study was performed retrospectively in 143 renal 
biopsies made for graft dysfunction with frozen and 
formalin-fixed, paraffin-embedded (FFPE) tissue available.
Immunofluorescence technique (Figures 1A and 
1C) was performed in 3μm frozen tissue, acetone-
fixed sections, using monoclonal antibody. The pri-
mary antibody used was Ms/Hm anti-C4d (clone 
033II-317.1.3.X by Quidel™, ref. A213) in dilution of 
1:30 over 30 minutes of incubation. The secondary 
antibody was Rb/Ms IgG-FITC (Dako™, ref. F261) in 
dilution of 1:20 over 30 minutes of incubation.
The indirect IHC technique (Figures 1B and 1D) was 
performed in paraffin-embedded tissue with polyclonal 
antiserum. The epitope retrieval was heat-induced at 
95-99ºC, over 20 minutes, at pH6, with the Target 
Retrieval Solution (Dako™, ref. S2369). The primary 
antibody used was polyclonal antibody Rb/Hm anti-C4d 
Immunofluorescence
A – Positive Diffuse
Immunohistochemistry
B – Positive Diffuse
C – Positive Focal D – Positive Focal
Figure 1
Positive C4d detection in peritubular capillaries according to technique and Banff classification. 
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(Serotec™, ref. 0030-0230) in a dilution of 1:30, over 
45 minutes. Others reagents used in this technique 
were Hydrogen Peroxide Block (Thermo Fisher Scien-
tific™, ref. TA-125-HP); Ultra V Block (Thermo Fisher 
Scientific™, ref. TA-125-UB); UltraVision ONE HRP 
Polymer (Thermo Fisher Scientific™, ref. TL-125-PHJ) 
and DAB+ (Dako™, ref. K3468).
The calculate cost was EUR 20.70 per biopsy by 
IF vs. EUR 38.63 per biopsy by IHC.
Biopsies were independently evaluated by two 
nephropathologists using the Banff 07 classification 
and scored negative (0-10%), positive focal (10-50%) 
and positive diffuse (>50%). In cases of non-concor-
dance the biopsies were reviewed together and clas-
sified according to consensus.
RESULTS 
By IF, C4d was always present in glomerulus; i.e. 
positive and negative cases for PTC C4d showed 
mesangial C4d staining (Figure 2A). The same was 
demonstrated for artery and arteriole endothelium. 
Using IHC, only PTC C4d positive cases presented 
staining in the glomerular basement membrane.
The results were summarised in Table I. There 
was total agreement on Banff classification in 87.4% 
(125/143) cases. All negative cases by IF were also 
negative by IHC. The biopsies were classified as 
positive in 44.7% (64/143) of cases performed by IF 
vs. 36.4% (52/143) performed by IHC. Fewer biopsies 
were classified as positive diffuse in the IHC group 
(25.1% vs. 31.4%) and more as positive focal (13.2% 
vs. 11.1%). More cases were classified as negative 
by the IHC method (63.6% vs. 55.2%).
Study by ROC curve showed that IHC has a speci-
ficity of 100% and a sensitivity of 81.2% in relation 
to IF (AUC: 0.906; 95% confidence interval: 0.846-
0.949; p=0.0001).
Table I
C4d detection in peritubular capillaries according to technique and Banff 
classification.
C4d Banff Classification Cases
Immunofluorescence Immunohistochemistry n=143
+Diffuse +Diffuse 36 (25.2%)
+Diffuse +Focal 6 (4.2%)
+Diffuse Negative 3 (2.1%)
+Focal +Focal 10 (7%)
+Focal Negative 9 (6.3%)




B – Positive Diffuse
Figure 2
By IF, positive and negative cases for PTC C4d showed mesangial C4d staining (A). By IHC, only PTC C4d positive cases presented staining in the glomerular 
basement membrane (B).
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1 – Excellent specificity. The results obtained in 
this study confirm and extend the results from 
other authors with a lower number of cases. 
No false positive cases were registered in our 
study.
2 – Feasible in formalin-fixed, paraffin-embedded 
tissue. FFPE is the usual tissue processing for 
kidney biopsies, so this material is always 
available. The IHC technique could be used 
when no frozen tissue is accessible.
IHC DISADVANTAGE 
1 – Lower sensibility. Although IHC presents an 
excellent specificity, it has a lower sensitivity 
than IF. Some false negative were registered. 
The positive staining area by IHC is in some 
cases lower than by IF cases. That explains 
some discrepancies between classifications: 
positive diffuse by IF was graded as positive 
focal by IHC. Results obtained with IHC must 
be interpreted with some reserve since clinical 
relevance has only been established for IF 
results, and a focal staining in IHC can cor-
respond to a diffuse staining in IF, for 
example.
2 – Nonspecific staining. Both nephropathologists 
stated that IHC staining causes more difficul-
ties in interpretation, due to the existence of 
unspecific staining in tubular cells and sur-
rounding interstitium. This was also referred 
to in other studies9. To overcome this issue, 
transplantation centres and laboratories must 
establish protocols to minimise the impact of 
preanalytical factors in IHC, and laboratories 
must follow strict protocols both in analytical 
and postanalytical procedures12.
3 – Cost and time preparation. The IHC technique 
was approximately EUR 18 per biopsy, more 
expensive than IF. The IHC method takes over 
one hour more to complete than the IF tech-
nique. The IF technique is applied to frozen 
sections, does not need previous processing 
and can be finished in one hour. By IF method 
the results can be available to medical staff 
less than two hours after tissue reception in 
the laboratory.
4 – Need for external controls. Since mesangium 
and artery endothelium in frozen sections are 
always C4d positive (Figure 2A), there is no 
need for an external positive control. In IHC 
(Figure 2B) we recommend the use of two exter-
nal positive controls – one with focal and the 
other with diffuse staining. When that is not 
possible, human tonsil specimens from acute 
tonsillitis can also be used as a positive control 
as C4d presents strong staining in germinal 
centres of secondary lymphoid follicles13.
CONCLUSIONS 
The IHC method presents an excellent specificity 
but lower sensitivity to C4d detection in allograft 
dysfunction. The evaluation is more difficult, requir-
ing a more experienced observer than the IF method. 
In our laboratory, the use of IHC for C4d detection 
seems to us acceptable and safe when frozen tissue 
is unavailable. Extensive studies should be made to 
determine the real correspondence between results 
of both techniques and to establish guidelines for 
the interpretation of IHC results.
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